Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hodgkin Disease × Dacarbazine × Clear all

Phase

Phase 2 28 Phase 3 20 Phase 1/2 3 Phase 1 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Melanoma 1 Lymphoma 1 Hodgkin Disease 1

Interventions

Brentuximab Vedotin 3 Vinblastine 2 Radiotherapy 2 Cyclophosphamide 2 tislelizumab 1 sintilimab 1 prednylidene 1 Watchful Waiting 1 Thiotepa 1 Prednisolone 1 Pentoxifylline 1 Filgrastim 1 Doxorubicin 1 Dacarbazine 1 Bendamustine Hydrochloride 1 Antilymphocyte Serum 1 ABVD protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06831370 2026-02-23

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Takeda

Phase 4 Recruiting

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡